- Discovery and Preclinical Development of ANT3310 a Broad-Spectrum Serine β-Lactamase Inhibitor which Potentiates Meropenem against Carbapenem Resistant Bacteria
David Davies. Antabio
- Impact of Standard of Care Parkinson's Disease medications on Off-time readouts in clinical trials. A Quantitative Systems Pharmacology (QSP) approach
Emma Mitchell, Rachel Rose, Hugo Geerts. Certara
- Leveraging genetic data to investigate the effects of interleukin-6 receptor signalling on levels of 40 circulating cytokines
Rezbieara Rahman. St George's University of London
- Pre-clinical validating of RAR-M NVG-645 for disease-modification of ALS
Paul Chazot1, Andrew Whiting1, Peter McCaffery2. 1Durham University, 2Aberdeen University
- Pre-clinical validation of a novel CNS-sparing histamine-binding drug, Votucalis, for chronic neuropathic pain
Paul Chazot1, Ilona Obara2, Miles Nunn3. 1Durham University, 2Newcastle University, 3Akari therapeutics
- Risk Management in Phase I Clinical Trials
Jorg Taubel. Richmond Research Institute
- Uncovering Novel Drugs That Restore Vision By Combining Biological and Computational Drug Discovery Processes
Justine O'Brien1, Andrea Cerquone Perpetuini2, Robert Scoffin3, Breandan Kennedy2. 1UCD School of Biomolecular and Biomedical Science, 2UCD Conway Institute, UCD School of Biomolecular and Biomedical Science, 3Cresset Biomolecular Discovery Ltd